CLDX icon

Celldex Therapeutics

85 hedge funds and large institutions have $11.3M invested in Celldex Therapeutics in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 27 reducing their positions, and 20 closing their positions.

Holders
85
Holders Change
-10
Holders Change %
-10.53%
% of All Funds
1.9%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
10
Increased
22
Reduced
27
Closed
20
Calls
$13K
Puts
Net Calls
+$13K
Net Calls Change
+$15K
Name Market Value Shares Shares
Change
Shares
Change %
ProShare Advisors
76
ProShare Advisors
Maryland
-66,244 Closed
Bank of America
77
Bank of America
North Carolina
$0 1,445 -32,085 -96%
Principal Financial Group
78
Principal Financial Group
Iowa
-20,650 Closed
LP
79
LMR Partners
United Kingdom
-20,442 Closed
FWCM
80
Ferguson Wellman Capital Management
Oregon
-16,100 Closed
Koshinski Asset Management
81
Koshinski Asset Management
Illinois
-14,200 Closed
TSS
82
Two Sigma Securities
New York
-12,093 Closed
Man Group
83
Man Group
United Kingdom
-11,000 Closed
BWP
84
BSW Wealth Partners
Colorado
-10,181 Closed
Barclays
85
Barclays
United Kingdom
$0 78 -6,938 -99%
IP
86
Intellectus Partners
California
-4,000 Closed
RMAM
87
Raab & Moskowitz Asset Management
New Jersey
-1,000 Closed
FANJ
88
Financial Architects (New Jersey)
New Jersey
$0 2,245 -900 -29%
KF
89
Krilogy Financial
Missouri
-600 Closed
MSA
90
Marino Stram & Associates
Massachusetts
-166 Closed
ML
91
McAdam LLC
Pennsylvania
-42 Closed
Walleye Trading
92
Walleye Trading
New York
-40 Closed
CF
93
Centaurus Financial
California
-25 Closed
PMFA
94
Plante Moran Financial Advisors
Michigan
-8 Closed
Simplex Trading
95
Simplex Trading
Illinois
SWP
96
Strategic Wealth Partners
Ohio
$0 1,000
AIM
97
Advantage Investment Management
Iowa
$0 1,725
FHA
98
Flagship Harbor Advisors
Massachusetts
$0 16
IA
99
IFP Advisors
Florida
$0 900
FWM
100
Focused Wealth Management
New York
$0 350